| 000 | 01482 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513102020.0 | ||
| 264 | 0 | _c19961210 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/BF00879871 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlimov, A N | |
| 245 | 0 | 0 |
_a"Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cDec 1995 |
||
| 300 |
_a779-84 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aFat Emulsions, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aNiacin _xtherapeutic use |
| 650 | 0 | 4 |
_aPhosphatidylcholines _xtherapeutic use |
| 700 | 1 | _aKonstantinov, V O | |
| 700 | 1 | _aLipovetsky, B M | |
| 700 | 1 | _aKuznetsov, A S | |
| 700 | 1 | _aLozovsky, V T | |
| 700 | 1 | _aTrufanov, V F | |
| 700 | 1 | _aPlavinsky, S L | |
| 700 | 1 | _aGundermann, K J | |
| 700 | 1 | _aSchumacher, R | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 9 _gno. 6 _gp. 779-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00879871 _zAvailable from publisher's website |
| 999 |
_c8844550 _d8844550 |
||